2-(2,3-dicarboxycyclopropyl)glycine has been researched along with lamotrigine in 1 studies
Studies (2-(2,3-dicarboxycyclopropyl)glycine) | Trials (2-(2,3-dicarboxycyclopropyl)glycine) | Recent Studies (post-2010) (2-(2,3-dicarboxycyclopropyl)glycine) | Studies (lamotrigine) | Trials (lamotrigine) | Recent Studies (post-2010) (lamotrigine) |
---|---|---|---|---|---|
166 | 0 | 27 | 3,550 | 501 | 1,351 |
Protein | Taxonomy | 2-(2,3-dicarboxycyclopropyl)glycine (IC50) | lamotrigine (IC50) |
---|---|---|---|
Sodium channel protein type 2 subunit alpha | Homo sapiens (human) | 10 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Attwell, PJ; Bradford, HF; Croucher, MJ; Jane, DE; Singh Kent, N | 1 |
1 other study(ies) available for 2-(2,3-dicarboxycyclopropyl)glycine and lamotrigine
Article | Year |
---|---|
Anticonvulsant and glutamate release-inhibiting properties of the highly potent metabotropic glutamate receptor agonist (2S,2'R, 3'R)-2-(2',3'-dicarboxycyclopropyl)glycine (DCG-IV).
Topics: Amygdala; Animals; Anticonvulsants; Aspartic Acid; Cerebral Cortex; Cyclopropanes; Glutamic Acid; Glycine; Kindling, Neurologic; Lamotrigine; Male; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Seizures; Synaptosomes; Triazines | 1998 |